BlackRock’s Aura Biosciences AURA Stock Holding History

BlackRock’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24M	Buy	3,586,640 +26,216	+0.7%	+$150K	﹤0.01%	2958
2025 Q4	$19.4M	Buy	3,560,424 +154,947	+5%	+$920K	﹤0.01%	3122
2025 Q3	$21M	Buy	3,405,477 +302,953	+10%	+$1.98M	﹤0.01%	3066
2025 Q2	$19.4M	Sell	3,102,524 -437,424	-12%	-$2.56M	﹤0.01%	3049
2025 Q1	$20.7M	Sell	3,539,948 -11,509	-0.3%	-$87.1K	﹤0.01%	2917
2024 Q4	$29.2M	Buy	3,551,457 +391,043	+12%	+$3.68M	﹤0.01%	2804
2024 Q3	$28.2M	Buy	3,160,414 +155,052	+5%	+$1.33M	﹤0.01%	2815
2024 Q2	$22.7M	Buy	3,005,362 +560,521	+23%	+$4.11M	﹤0.01%	2905
2024 Q1	$19.2M	Buy	2,444,841 +346,096	+16%	+$2.87M	﹤0.01%	3014
2023 Q4	$18.6M	Buy	2,098,745 +234,719	+13%	+$1.99M	﹤0.01%	3050
2023 Q3	$16.7M	Sell	1,864,026 -8,106	-0.4%	-$87.2K	﹤0.01%	3046
2023 Q2	$23.1M	Buy	1,872,132 +541,032	+41%	+$5.78M	﹤0.01%	2940
2023 Q1	$12.4M	Buy	1,331,100 +277,973	+26%	+$2.89M	﹤0.01%	3202
2022 Q4	$11.1M	Buy	1,053,127 +39,672	+4%	+$505K	﹤0.01%	3351
2022 Q3	$18.4M	Buy	1,013,455 +126,732	+14%	+$1.92M	﹤0.01%	3083
2022 Q2	$12.6M	Buy	886,723 +611,696	+222%	+$10.1M	﹤0.01%	3385
2022 Q1	$6.05M	Buy	275,027 +36,244	+15%	+$690K	﹤0.01%	3859
2021 Q4	$4.05M	Buy	+238,783	New	+$4.27M	﹤0.01%	4083

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock's AURA Position: Q1 2026 in Review

BlackRock increased its Aura Biosciences (AURA) stake by 0.74% in Q1 2026, buying an estimated $150K and bringing the position to 3,586,640 shares worth $24M. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

BlackRock first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $29.2M in Q4 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

BlackRock held 3,586,640 shares of Aura Biosciences worth $24M as of Q1 2026.
BlackRock bought 26,216 Aura Biosciences shares in Q1 2026, an estimated $150K.
Aura Biosciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2958 holding.
BlackRock first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
BlackRock's Aura Biosciences position peaked at $29.2M in Q4 2024.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.